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Abstract
Background: Private sector medicine outlets are an important provider of health services across the developing world,
and are an untapped means of distributing and selling vaccines outside of childhood immunization programs.
The present study assessed the viability of medicine outlets (chemists and pharmacies) as potential channels
for sale of vaccines.
Methods: To evaluate the viability of the medicine outlet model, we partnered with nine outlets across urban and
rural communities in western Kenya to sell a nurse-administered typhoid vaccine. Purchasers were surveyed to reveal
market demographic characteristics, reasons for vaccine purchase, and sources of information about the program. Key
informant interviews and focus group discussions defined acceptability, demand, and additional suggestions for
improving this mechanism of selling and distributing vaccines.
Results: There was a higher than expected demand for the vaccine that resulted in stock-outs. Previous instance
of typhoid, desire to prevent disease, affordable price and convenience were cited by most participants as main
reasons for purchase of vaccine at the local outlet. The most common source of information on the vaccine sale
was word-of-mouth and referral from friends. Longer vaccine sale duration, adequate stocking of vaccines and
extended hours of administration in the evening to allow working individuals to buy vaccines were cited by
participants as ways for improved participation in the future.
Conclusions: This study demonstrated a high demand for vaccines at community medicine outlets. Important
insights on how to improve and sustain such a program included extension of distribution time, education of
outlet keepers, and minimizing vaccine stockouts. With improved social marketing, infrastructure mapping, education
and pricing schemes, medicine outlets could become a sustainable avenue for selling adult vaccines in emerging
markets for both routine and pandemic vaccines.
Background
The current immunization agenda heavily emphasizes
childhood vaccination with the Global Vaccine Action
Plan (GAVI) setting vaccination coverage target of ≥90 %
nationally [1, 2]. Indeed, in most developing countries,
immunization schedules are designed around the
Expanded Program on Immunization-a set of essential
vaccines to be given in infancy and early childhood [3].
The trend has been to integrate vaccine distribution into
the delivery of maternal and child health services [4, 5] or
in supplemental immunization campaigns and special
child health days [6, 7]. These efforts have resulted in sig-
nificant increases in childhood immunization rates.
In contrast, relatively little attention has been paid to
vaccination among older populations. The immunization
needs of older age groups is a major challenge 21st
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century, as childhood coverage improves and rising life
expectancy results in different, more chronic diseases as-
suming the global burden of disease [8, 9]. These include
current and future vaccines against food-borne and
sexually transmitted diseases, neglected tropical diseases,
and emerging pandemics, which necessitate reaching a
broad age range. Even in the developed world, adult
immunization is considered lacking in terms of its out-
comes, funding, and policy framework when compared
to children [10–12]. Alternative models of vaccine distri-
bution, which can reach older populations are needed to
meet the needs of massive rollouts.
The private retail sector has recently played an import-
ant role in the USA, particularly for flu vaccination [13].
We thus hypothesized that the private sector could be
tapped for increasing immunization rates in the develop-
ing world. The retail pharmaceutical sector includes a
variety of chemists and pharmacies that are highly ubi-
quitous across both high and low income countries.
These medicine outlets vary in their services, products
and scope of practice, and some of the owners, in particu-
lar of chemists, often do not have any formal medical
training or certification to act as bona fide healthcare pro-
viders [14, 15]. Nonetheless, outlet keepers (those man-
ning outlets) frequently serve as a first point of medical
consultation and dispense drugs and health products to
millions of customers [16]. Because of their proximity, ac-
cessibility, and relationships with local communities,
medicine outlets represent an important potential partner
in immunization efforts for older populations or during
emergency pandemics as a viable mechanism to generate
revenue for research and development on much needed
new vaccines.
This study was a proof-of-concept exploring the use of
medicine outlets for the distribution and sale of vac-
cines. The objective of the study was to assess the viabil-
ity of medicine outlets as potential channels for sale of
vaccines geared toward adult populations. We recruited
owners of chemists and pharmacies in peri-urban and
rural western Kenya to sell a nurse-administered adult
vaccine for typhoid fever, a local endemic disease. Cus-
tomer and sales data were collected to determine the
feasibility and potential demand for vaccination at these
sites. This study demonstrates the practicality of devel-
oping the network of medicine outlets as relevant vac-




The study took place in western Kenya, within the cities
of Kisumu (population 500,000; 30 % unemployment
rate; 50 % absolute poverty) and Kakamega (population
600,000; 30 % unemployment rate, 57 % absolute
poverty) where chemists and pharmacies are important
and relatively well-documented sources of health ser-
vices [17–20]. Both regions are known to have poor ac-
cess to public health care facilities.
Selection of medicine outlets
Any chemist or pharmacy that stocks and sells medicines
was defined as a medicine outlet. Five outlets in Kakamega
County were tested: one from each of three randomly se-
lected urban informal settlements - Maraba, Amalemba,
and Lurambi, and two in rural settings - Bushiri and
Makunga. Four medicine outlets were chosen in Kisumu
County: three from randomly selected urban informal set-
tlements - Obunga, Nyalenda, and Manyatta, and one in a
rural setting - Nyahera. The outlets were chosen based on
willingness of the outlet owner/keeper to participate in
the study and record purchasing data from clients.
Outlets were evaluated for 3 days prior to study in order
to generate baseline data on the types of medicines pur-
chased and overall volume of sales. Chemist owners and
outlet keepers were trained in the collection of purchasing
data before and during vaccine distribution using a mobile
application on smartphones, enabling the collection and
uploading of all field data on site. Open Data Kit (ODK)
(Dept of Computer Science and Engineering, University of
Washington) was used to build a data collection
form, accessible by devices using the Android operat-
ing system, which uploaded responses in.xls format to
an online database created with Google App Engine
(Google Inc.- Mountain View, CA). The questionnaire
on the smartphones gathered customer demographic
information (name, age, gender, occupation), how cus-
tomers heard about the study, and their reasons for
purchase of vaccines.
Community sensitization
A road show was utilized to advertise the vaccine cam-
paign in public locations prior to the sale of the vac-
cines. A truck was affixed with banners promoting
typhoid vaccine and equipped with a public address sys-
tem, which broadcasted messages about the study. Team
members accompanied the vehicle and answered ques-
tions from those who attended. The second component
of publicity efforts took place at the selected chemists
and pharmacies. Each site was provided with laminated
posters and paper brochures containing information
about typhoid vaccination.
Sale and administration of typhoid vaccine
We selected a typhoid vaccine (Typhim Vi- Sanofi
Pasteur, Lyon, France) as a prototypical product for vac-
cines for adults and which is not part of any childhood
immunization programs. Vaccines were purchased from a
supplier (Laborex Chemist- Kisumu, Kenya) at a market
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price of ~9.0 USD per dose, and were sold for a price of
~50 Kenya shillings (KSh) (~0.6 USD). The medicine out-
let owners were allowed to keep all revenues from vaccine
sales. Five experienced nurses in vaccination protocols
who were registered with the Nursing Council of Kenya
(NCK) were recruited to administer the vaccine. Nurses
were trained on the use of a mobile phone platform for
data collection. Following community advertising, nurses
were stationed in the designated chemists and pharmacies,
and administered the vaccine during business hours for a
planned distribution period of up to 3 days. The vaccine
was maintained centrally under refrigeration at IRSK of-
fices where the nurses collected their daily supplies in
temperature-monitored cooler boxes every morning, and
returned any left over at the end of the day for cold
storage. After receiving the vaccine, customers were is-
sued official immunization certificates and asked to
complete a short, oral questionnaire administered by
the nurses and the opportunity to participate in a group
discussion (described below). Chemists and pharmacies
maintained normal operations during this time.
Key informant interviews and focus group sessions
After administration of the vaccine, key informant inter-
views (KII) were conducted with outlet keepers and
nurses who participated in the study. The interviewers
encouraged free and open responses highlighting the
challenges and opportunities encountered during vac-
cine distribution.
Three focus group discussions (FGD) with community
participants were also conducted, including those who
purchased the vaccine and those who did not purchase.
These consisted of two groups of 8–12 participants per
village, one consisting of males and the other females.
Three primary topics were explored in the FGDs: 1) per-
ceptions on the effectiveness of social mobilization tools
in enhancing the knowledge of typhoid fever and its im-
pact in increasing the demand and uptake of the vaccine;
2) factors that contributed to participation and non-
participation of community members in the study; 3)
willingness to pay for a vaccine and price points. We
also gathered recommendations for future vaccine cam-
paigns through medicine outlets.
Analysis
Sales information collected from medicine outlets and
customer surveys were input into spreadsheets. All KIIs
and FGDs were tape recorded and transcribed. Textual
data was fed into qualitative analysis software (ATLAS/ti
6.0- ATLAS.ti GmbH, Berlin, Germany) where it was
coded with selected themes. A master sheet analysis was
then carried out, using all the responses from the FGD
and interviews. Responses were translated to English
and interpreted by selecting patterns in the responses
and formulating themes which could account for those
responses. These responses were then presented in table
format. Quantitative data formatting, standardization
and analysis were carried out using both Excel and
STATA 12 (Stata Corporation, College Station, TX.).
Results
Baseline outlet sales prior to vaccine campaign
Outlet keepers across the nine study sites recorded base-
line data on a total of 1735 customer transactions. Two
of the sites collected data over a period of four consecu-
tive days, while the remainder collected data for 3 days.
Baseline sales showed that the most common category
of product purchased was analgesics (28.2 %), followed
by antibiotics (24.2 %). Remaining categories were al-
lergy medication (3.1 %), anti-malarials (9.6 %), other
anti-microbials (6.2 %), cold medication (2.8 %), contra-
ceptives (7.7 %), nutritional supplements (8.7 %) or other
(9.5 %). Using the value of each transaction, we calcu-
lated summary statistics on all items (irrespective of cat-
egory) to illustrate the typical range of costs for
products sold in medicine outlets. The cheapest items
tended to be analgesics, while prescription antibiotics
constituted the most expensive purchases (Table 1).
Vaccine customer characteristics
Data was collected on 613 customers at the time of vac-
cine administration. Vaccine purchase was equal be-
tween male (50.1 %) and female (49.9 %) participants,
with a mean age of 35.9, median age of 32, and a stand-
ard deviation of 12.8 (Table 2). Customers were next
asked to share their reasons for purchasing a vaccine.
Affordable price was by far the most common reason,
cited by 56.0 % of respondents (Table 3). Finally, cus-
tomers were asked on how they heard about the vaccine
sale exercise at their local outlet. The single most com-
mon source of information was word-of-mouth and re-
ferral from friends (46.8 % of respondents). Road shows













1 190 58.22 40 68.36 5 570
2 150 27.07 15 26.21 5 130
3 235 65.32 40 99.25 5 800
4 139 85.18 50 95.81 10 540
5 155 65.52 50 59.17 10 300
6 290 40.99 30 42.13 2 350
7 79 51.03 50 30.12 8 100
8 277 62.96 50 57.88 10 560
9 220 93.47 80 67.51 6 400
All outlets 1735 61.32 49 68.86 2 800
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(18.4 %) and promotional materials (brochures/posters)
at medicine outlets (15.7 %), the two major publicity ef-
forts, did not reach the majority of customers. Other
sources, including announcements from outlet keepers
and the internet, were cited by 25.8 % of respondents.
Focus group results
Opinions about distribution and service at the medicine
outlets
Participants were generally positive about the process of
vaccine distribution. From the community perspective,
most said they would still buy the vaccine if it was sold
in the future. When asked about the difference between
sites of sale, the medicine outlets versus hospital, the
majority of participants cited convenience and cost as
motivators for buying from a medicine outlet. Cus-
tomers stated that hospitals were farther away, required
long waiting times and medical consultation before vac-
cination, and charged more fees.
“At the hospital, you have to plan. You decide ‘I will
wake up at this time’ and so on, but at the chemist or
pharmacy you can continue with your own business
and access is easy.” - adult male from Kakamega.
Many people indicated they were hesitant to visit hos-
pitals for fear of queues and complications in service.
Community chemists were often a more desirable venue
to seek healthcare in general:
“Chemists usually are in the centre of the community
so most of the people rush there for prevention. I
think one will seek help there first, when things are
difficult is when you go to the hospital” - adult female
from Kisumu.
Reasons for purchase
The majority of focus group participants from the com-
munity cited a previous instance of typhoid, often mul-
tiple episodes in past years, as their main reason for
buying the vaccine. The desire to prevent the disease
was also mentioned by many who did not report a past
infection. A common theme among participants was to
rationalize the purchase of vaccine in economic terms:
“I felt vaccination protection is better than cure, the
cost of treatment is much higher than protection.
Better to protect myself than to get the disease and
seek treatment.” - adult female from Kakamega.
All participants reported that they were very satisfied
with the service provided by nurses in the exercise, both
in how they educated customers and how they adminis-
tered the vaccine. Some said the presence of a uniformed
nurse made them feel more comfortable, evoking a hos-
pital setting.
Affordability
Participants stated that the outlet price was significantly
lower than the usual cost of receiving vaccine at hospitals
- reported figures ranged from 400 to 1500 KSh - and
compared favorably to the cost of treating typhoid. Never-
theless, a minority believed that 50 KSh would still present
a challenge to some of the poorest (and especially rural)
members of the community; a reduction to 20–30 KSh
was suggested. Most participants believed that increasing
the price of the vaccine, to 100 KSh or 200 KSh, would re-
sult in lower uptake. However, it should be noted that
products purchased from the outlets were as high as 800
KSh (Table 1). Those willing to purchase a more expensive
vaccine were predicted to be those who were acquainted
with the cost of treatment.
Reasons for not purchasing a vaccine
Most of the reasons participants gave for not purchasing
the vaccine were related to lack of access. More than half
of the participants reported their key reason was the vac-
cine shortage. Due to greater than expected demand,
medicine outlets were out of stock during publicized days
of distribution, resulting in consumers being turned away.
This was complemented by the common complaint that
Table 2 Socio-demographic characteristics of vaccine
customers







Food handler 56 9.1
Teacher 41 6.7
Other or unemployed 201 32.8
*Total percentage exceeds 100 % because respondents reported multiple jobs
Table 3 Reasons for purchasing vaccine
Reason Frequency (n = 613) Percentage (%)
Affordable price 343 56.0
Typhoid prevention 229 37.4
General health 19 3.1
Availability 15 2.4
Past history of typhoid 12 2.0
Other 5 0.8
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daytime hours of distribution were in conflict with con-
sumer’s work schedule or other commitments. A few re-
spondents were not aware of the distribution exercise
until the material day, which presented a financial chal-
lenge or otherwise prevented them from making a pur-
chase decision.
Outside of access, an important issue was consumer
concern regarding whether the vaccine had been stored
properly, and whether the staff was trained. Some con-
sumers were cautious of the outlet keeper’s motives, not-
ing that business owners may pay more attention to
making vaccine sales than proper procedure. Others
raised questions about the authenticity of the vaccine.
Some participants also voiced concerns and suspicions
about potential side effects, or that the injections were
part of a sterilization/family planning scheme. For other
participants, receiving the vaccine from a pharmacy was
acceptable as long as the outlet was recommended or
certified by the government, could demonstrate the vac-
cines came from a legitimate source, and had medical
authorization to give them. Only a few participants said
they would not buy vaccines from the outlet again, say-
ing they would feel safer at the hospital with specialists.
At least one community member appreciated the med-
ical examinations which accompany vaccination at the
hospital, and was skeptical that sped-up administration
at the pharmacy was appropriate.
Key informant interview results
Outlet keepers
All outlet keepers strongly felt that this vaccine distribu-
tion exercise was a worthwhile activity. Outlet keepers
liked revenue generated from sales. Many expressed will-
ingness to take on the role of administering vaccines in
the future - one pointed out that some pharmacists
already administer birth control injections - and would
be comfortable with additional training.
Nurses
Being the only participants to have experienced the exer-
cise at multiple sites, nurses reported differences in ser-
vice provision between locations. One nurse observed
one outlet keeper who did not actively mention the vac-
cine and exhibited condescending attitudes towards her
customers of lower socio-economic status. Another
nurse initially observed low participation in her setting,
and after talking to the community realized the outlet
keeper commanded little respect. In contrast, uptake
was high at one site where the outlet keeper was noted
to be very well informed and trusted. Some outlet
keepers and nurses reported that a few customers mis-
conceived the program to be a clinical trial of an experi-
mental vaccine or fertility drug.
Suggestions for improvements from all study participants
Though the reception to the exercise was largely
positive, participants offered numerous suggestions for
future vaccine distribution (summarized in Table 4).
The majority felt that the timeframe was a barrier to
access; the overall schedule (3 days) should be ex-
tended to at least 1 week. A lengthened campaign
could also potentially mitigate overcrowding at the
medicine outlets. At a minimum, participants felt that
outlets should be stocked with sufficient inventory.
Stockouts in the present study resulted in many sites
concluding their sales prematurely and wasted cus-
tomer time. Finally, extended hours of administration
in the evening would allow working individuals to be
vaccinated.
Discussion
Robust participation in the exercise and feedback from
focus group discussions suggest that selling vaccines
through medicine outlets is a promising model for in-
creasing vaccine distribution. Both the availability of vac-
cines through medicine outlets and subsidized prices
increased accessibility to vaccines. Customers found the
new location of vaccine administration to be advanta-
geous with respect to accessibility and convenience. The
barriers to vaccination we identified in the communities
in western Kenya, including the distance to hospitals
and long wait, echo the findings of vaccination studies
in other settings around the world [21, 22]. Resources
and time expended on travels negatively affect adult vac-
cine uptake. The optimal placement of distribution sites
has been the subject of previous study [23]. Medicine
outlets, which are embedded in the communities they
serve, are well-situated to reduce the indirect costs of
vaccination. It was also noted that hospitals already refer
patients to pharmacies and sometimes medicine outlets
to purchase medicine, lending them additional credibility
in providing health services.
Table 4 Summary of Focus group suggestions on distribution,
sensitization and publicity
Lengthen vaccine distribution period to at least 1 week
Bring significantly more vaccines to each site
Sell vaccine in the evenings after work hours
More time between mobilization and delivery (at least 2 days’ notice)
Liaise with the chief, bring up vaccine distribution at chief’s baraza
(community gathering)
Inform the local public health officers
Post materials at schools (give to children) and in churches to reach
different segments of pop
Advertise on the radio
Use community health workers for door-to-door outreach
Ho et al. BMC Health Services Research  (2016) 16:527 Page 5 of 8
To better understand how this partnership with the
local private sector may be generalized, it is worth con-
sidering the well-documented and successful use of pri-
vate medical vendors in distributing anti-malarial
medications in sub-Saharan Africa. The global effort to
make artemisinin-based combination therapies, the
current first-line treatment for malaria, less expensive and
available at medicine outlets has been a widely hailed ini-
tiative that invites comparison: by utilizing the private for-
profit sector, there have been large increases in the acces-
sibility and use of a product which previously was limited
to the clinical setting [24]. Many of the concerns
expressed by participants in this study are closely related
to previously identified barriers to malaria treatment [25].
The policy implications of involving retail pharmacies in
malaria control - adherence to treatment guidelines,
quality assurance, and social responsibility of using
profit-seeking entities - have also been explored in lit-
erature [26, 27]. For any expansion of vaccination
through medicine outlets, similar aforementioned pol-
icy issues will need to be the subject of more in-depth
studies.
One of the few benefits to seeking care at hospitals
was the reassurance provided from being seen at a
formal institution. Likewise, the study nurses were ef-
fective because their uniforms and official qualifications
created trust in the community. If outlet keepers could be
trained on safe storage, injection, and potential side ef-
fects, the majority of customers would likely be willing to
receive vaccines directly from them. Development of this
vaccinator training program would require navigating
local legal frameworks and input from Ministries of
Health. Also worth considering are the many regulatory
challenges introduced by broadening vaccine sales, such
as registered inventory, inspection of facilities, certification
of personnel, and enforcement. The literature on malaria
control again offers insight on these issues, and provides
examples of successful interventions to improve retailer
practices and engage them in broader government health
initiatives [16, 28, 29].
Interestingly, we found that word-of-mouth was the
most powerful source of information to inform com-
munities of the vaccine program. The role of peers in
disseminating information is a type of “social learning”
that influences health behavior in developing countries
[30, 31]. Restructuring our program to utilize this
process - by increasing the lead time between publicity
and the start of vaccine sales, and by lengthening the
period of distribution - would enable information about
the campaign and people’s experiences to disseminate
further. In this way, community sensitization could be
improved without much additional expenses.
The low price of the highly subsidized vaccine in this
study was a major asset in creating high customer demand
for vaccination in outlets. The vaccines were sold for
50KSh, compared to a typical price of 400–1500 KSh
for hospital-sold vaccines. The 50Ksh price was com-
parable to the mean price of other items sold. Most
participants felt that this was affordable, and that in-
creasing the price would result in lower demand, al-
though pricing could vary depending on settings. The
household willingness-to-pay for typhoid vaccine has
been previously described in other settings, and find-
ings from the present study are consistent with the
view that vaccines are products exhibiting price elasti-
city [32]. If the model in the present study was ever
generalized, medicine outlets would play a role in set-
ting vaccine prices; however, the vendor-optimal price
for maximizing profits may not be in line with the so-
cial goal of maximizing vaccine uptake. More research
is thus needed to elucidate the balance between afford-
ability and profit incentives for outlet keepers in each
particular setting and the public health need for vac-
cines outside of childhood immunization programs
[33]. One barrier to vaccine distribution is poor electri-
city infrastructure in most rural settings in developing
countries that would significantly impact on storage of
vaccines and affect the cold-chain process required for
most vaccines.
Considering the inadequate vaccine inventory during
the exercise, reliable data collection should be considered
a core function essential to supply chain management and
the logistics of any sustainable distribution network for
vaccines [34]. Data collection application tools that can be
readily used by nurses and other portable technologies
can play important roles in effectively delivering vaccines
from suppliers to populations of need.
Conclusion
It is important to recognize that the medicine outlet
model is not a panacea for achieving universal vaccine
coverage, but rather one to increase the supply chain for
adult and adolescent vaccines, including mass rollouts of
newly introduced vaccines, and would need to be supple-
mented by additional efforts to reach remote populations.
Important insights on how to improve and sustain such a
program included extension of distribution time, educa-
tion of outlet keepers, and minimizing vaccine stockouts.
With improved social marketing, infrastructure mapping,
education and pricing schemes, medicine outlets could
become a sustainable avenue for distributing vaccines in
emerging markets for both routine and pandemic vac-
cines. Navigating some of the policy considerations of in-
corporating outlet owners in national health strategies and
training a workforce in vaccine administration would also
improve the capacity of national health systems to address
future public health emergencies.
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